Loading organizations...
Loading organizations...
Innovative biopharmaceutical company developing oncology therapies.
Apollomics has raised $233.9M across 3 funding rounds.
Apollomics has raised $233.9M in total across 3 funding rounds.
Apollomics has raised $233.9M in total across 3 funding rounds.
Apollomics's investors include Dong Liu, Kexiang Zhou, Guo Liang Yu, Jonathan Wang.
Apollomics has raised $233.9M across 3 funding rounds. Most recently, it raised $124.2M Series C in November 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 6, 2020 | $124.2M Series C | Dong Liu | |
| Jan 8, 2019 | $100.0M Series B | Kexiang Zhou | Guo Liang Yu |
| Aug 29, 2016 | $9.8M Series A | Jonathan Wang |